Clinical Trial Update: A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

The document provides a status update on a Phase 2 trial of Casdozokitug in combination with Toripalimab and Bevacizumab for unresectable/metastatic hepatocellu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Casdozokitug (Casdozokitug)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING